Introduction Advanced heart failure (HF) represents a therapeutic challenge, characterized by quality of life deterioration and multiple hospitalizations. When HF is secondary to cardiac amyloidosis, the recommended treatment for HF may have an unfavorable clinical course. In advanced HF cases, the clinical scenario is even more challenging. […]